- Home
- FRGT vs CYCC Comparison
FRGT vs CYCC Comparison
Compare FRGT & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- CYCC
- Stock Information
- Founded
- FRGT 2015
- CYCC 1992
- Country
- FRGT United States
- CYCC United States
- Employees
- FRGT N/A
- CYCC N/A
- Industry
- FRGT Professional Services
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- CYCC Health Care
- Exchange
- FRGT Nasdaq
- CYCC Nasdaq
- Market Cap
- FRGT 2.1M
- CYCC 3.6M
- IPO Year
- FRGT N/A
- CYCC N/A
- Fundamental
- Price
- FRGT $0.96
- CYCC $0.27
- Analyst Decision
- FRGT
- CYCC Strong Buy
- Analyst Count
- FRGT 0
- CYCC 1
- Target Price
- FRGT N/A
- CYCC $11.00
- AVG Volume (30 Days)
- FRGT 256.1K
- CYCC 202.6K
- Earning Date
- FRGT 05-08-2025
- CYCC 05-13-2025
- Dividend Yield
- FRGT N/A
- CYCC N/A
- EPS Growth
- FRGT N/A
- CYCC N/A
- EPS
- FRGT N/A
- CYCC N/A
- Revenue
- FRGT $17,567,033.00
- CYCC $74,000.00
- Revenue This Year
- FRGT $144.53
- CYCC N/A
- Revenue Next Year
- FRGT $55.01
- CYCC $88.68
- P/E Ratio
- FRGT N/A
- CYCC N/A
- Revenue Growth
- FRGT N/A
- CYCC N/A
- 52 Week Low
- FRGT $0.93
- CYCC $0.26
- 52 Week High
- FRGT $42.50
- CYCC $4.00
- Technical
- Relative Strength Index (RSI)
- FRGT 34.76
- CYCC 37.24
- Support Level
- FRGT $0.93
- CYCC $0.27
- Resistance Level
- FRGT $1.30
- CYCC $0.32
- Average True Range (ATR)
- FRGT 0.10
- CYCC 0.02
- MACD
- FRGT -0.04
- CYCC -0.00
- Stochastic Oscillator
- FRGT 4.76
- CYCC 16.50
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.